Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants

Summary

This is a single arm dose escalation study of recombinant human keratinocyte growth factor given to patients undergoing allogeneic bone marrow transplantation who are at high risk for graft versus host disease (GVHD).

Timeline

Start

2002-09

Primary completion

—

Completion

2005-06

Drugs

Indications